Genmab — November 2016
-
Iøvrigt er der stadig mulighed for tech aftale med Novartis (der har været en vis skepsis af nogle skribenter)
-
Ja, HuMax-AXL-ADC er solide tumorer iflg Genmab slides
-
LeoPharma har indgaaet samarbejde med MorphoSys. De vil ind paa Genmabs omraade iflg finans.dk http://finans.dk/live/erhverv/ECE9120149/potentiel-milliardaftale-skubber-leo-pharma-laengere-ind-paa-genmabs-territorium/
-
LeoPharma / Morphosys samarbejdet er i foerste omgang inden for alvorlige hudsygdomme
-
Skal måske overveje Bull x5............i morgen...
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
